KONTRASTMITTEL

Patent europeic · EP3717025 · En vigur

Inscripziun en il register

Numer da publicaziun
EP3717025
Numer da la dumonda
EP18811010
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
27-11-2018
Publitgà
07-10-2020
Concedì
03-11-2021
La protecziun finescha il pli tard
26-11-2038
Proxima taxa annuala scadenta
30-11-2026
Classas IPC
A61K 51/04 (2006.01)
C07B 59/00 (2006.01)
C07D 491/048 (2006.01)
A61K 101/00 (2006.01)
A61K 101/02 (2006.01)
Prioritad
EP 17204896 01.12.2017
Dumonda PCT
PCT/EP2018/082649 27.11.2018
Publicaziun PCT
WO2019/105913 06.06.2019
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 01-12-2025

    Midada

    Published in Swissreg on 01.12.2025

  2. 01-12-2024

    Midada

    Published in Swissreg on 01.12.2024

  3. 01-12-2023

    Midada

    Published in Swissreg on 01.12.2023

  4. 01-12-2022

    Midada

    Published in Swissreg on 01.12.2022

  5. 14-09-2022

    Midada

    Published in Swissreg on 14.09.2022

  6. 03-11-2021

    Concedì

    Published in Swissreg on 03.11.2021

Partidas

Possessur

UCB Biopharma SRL

Allée de la Recherche 60, 1070 Brussels, BE

Inventur

MAGUIRE, Ralph

1070 Brussels, BE

VALADE, Anne

1070 Brussels, BE

MERCIER, Joël

1070 Brussels, BE

WOOD, Martyn

Brussels 1070, BE

VERMEIREN, Celine

1070 Brussels, BE

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.